Cargando…

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible

BACKGROUND: Anecdotal experience and studies have shown that most pediatric patients fail to reach target therapeutic vancomycin trough levels (VTLs) and required higher total daily doses (TDD). This retrospective study aims to evaluate the frequency of hospitalized children who achieved target VTLs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Kashif, Salat, Muhammad Sohail, Rauf, Shahzad, Rathi, Manoj, Khan, Midhat, Naz, Fizzah, Khan, Wasif Ahmed, Ikram, Rahila, Ambreen, Gul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392299/ https://www.ncbi.nlm.nih.gov/pubmed/35987842 http://dx.doi.org/10.1186/s40360-022-00606-1

Ejemplares similares

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Hussain, Kashif, et al.
Publicado: (2021)

Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study
por: Kumar, Manoj, et al.
Publicado: (2022)

Therapeutic drug monitoring of vancomycin by AUC(τ)-MIC ratio in patients with chronic kidney disease
por: Khoei, Ahmad, et al.
Publicado: (2019)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
por: Mcgrady, Kerri A., et al.
Publicado: (2020)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

2193. Vancomycin AUC:MIC Monitoring: Transitioning Safely from Inpatient to Outpatient Monitoring via OPAT
por: Campion, Maureen, et al.
Publicado: (2023)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
por: Seddon, Megan, et al.
Publicado: (2018)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

Safety and Feasibility Assessment of a Pharmacy-Driven AUC/MIC Vancomycin Dosing Protocol in a Multicenter Hospital System
por: Phillips, Morgan, et al.
Publicado: (2023)

Association between the AUC(0-24)/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis
por: Men, Peng, et al.
Publicado: (2016)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
por: Chen, Jihui, et al.
Publicado: (2021)

220. Acute kidney injury incidence comparison of vancomycin trough-based vs AUC/MIC monitoring at a tertiary care hospital
por: Ruiz Gaviria, Rafael E, et al.
Publicado: (2022)

Neurodevelopment Outcome of Neonates Treated With Intraventricular Colistin for Ventriculitis Caused by Multiple Drug-Resistant Pathogens—A Case Series
por: Hussain, Kashif, et al.
Publicado: (2021)

Successful Treatment of Invasive MRSA Infections in Children Using Area Under the Vancomycin Concentration-Time Curve Divided by the Minimum Inhibitory Concentration (AUC/MIC) to Measure Vancomycin Exposure
por: Chiang, Leslie, et al.
Publicado: (2021)

397 Correlation between calculated vancomycin AUC(0-24)/MIC and acute kidney injury in patients with Methicillin Resistant Staphylococcus Aureus bacteraemia
por: Ghosh, Niladri, et al.
Publicado: (2014)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

1310. Implementation of AUC:MIC Pharmacy to Dose in an Academic Medical Center: A Pilot Study
por: Idusuyi, Ann-Marie, et al.
Publicado: (2020)

Meropenem-induced pancytopenia in a preterm neonate: a case report
por: Hussain, Kashif, et al.
Publicado: (2021)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study
por: Ambreen, Gul, et al.
Publicado: (2022)

Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. aureus vancomycin MIC in a tertiary university hospital
por: Joana, Silvestre, et al.
Publicado: (2013)

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?
por: Othman, Hala B., et al.
Publicado: (2018)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

Evaluation of polymyxin B AUC/MIC ratio for dose optimization in patients with carbapenem-resistant Klebsiella pneumoniae infection
por: Wang, Peile, et al.
Publicado: (2023)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

349. The impact of Vancomycin dosing by area under the curve over minimal inhibitory concentration (AUC/MIC) versus Trough levels on cumulative Vancomycin dosage and incidence of Acute Kidney Injury (AKI) in patients admitted to intensive care units (ICU)
por: Sahu, Aniruddha, et al.
Publicado: (2023)

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing
por: Boyd, Allison N, et al.
Publicado: (2022)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023)

1395. Defining the Magnitude of AUC:MIC Driver for Efficacy of the β-Lactamase Inhibitor VNRX-5133 When Combined with Cefepime Against KPC- and VIM/NDM-Producing Enterobacteriaceae and P. aeruginosa
por: Daigle, Denis, et al.
Publicado: (2018)

The Open AUC Project
por: Cölfen, Helmut, et al.
Publicado: (2009)

EVALUATION OF METHODS IN DETECTING VANCOMYCIN MIC AMONG MRSA ISOLATES AND THE CHANGES IN ACCURACY RELATED TO DIFFERENT MIC VALUES
por: Rossatto, Fernanda Cristina Possamai, et al.
Publicado: (2014)

1091. Validation of an Allometrically Scaled Body Weight Equation to Predict Vancomycin Clearance and Guide 24-Hour Vancomycin AUC Dosing in Obese Patients
por: Footer, Brent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6av18pf49m1v6kb9qa1l8aufql